Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-009258

EVP, Research & CSO sold 7,900 shares at $71.16 ($562,161)

  • EVP, Research & CSO acquired 7,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-02-09 Option exercise +7,900 $1.53 $12,087 41,100 D
Virgin Herbert EVP, Research & CSO 2021-02-09 Sale −7,900 $71.16 $562,161 33,200 D
Derivatives
Virgin Herbert EVP, Research & CSO 2021-02-09 Option exercise · Stock Option (Right to Buy) −7,900 372,255 D
Open-market sales · 7,900 sh · avg $71.16 · $562,161
Loading xslF345X03/doc4.xml…